{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:52:06Z","timestamp":1787953926647,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cbi.2023.110351","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T01:35:51Z","timestamp":1673487351000},"page":"110351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine"],"prefix":"10.1016","volume":"371","author":[{"given":"Ryan","family":"Mortlock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Nesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleesha","family":"Bertoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"El Mekkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Kakuzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"De Rubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cbi.2023.110351_bib1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ajcn\/nqac005","article-title":"Emergence of the obesity epidemic: 6-decade visualization with clinicaloid avatars","volume":"115","author":"Wong","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.cbi.2023.110351_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18773\/austprescr.2017.053","article-title":"Drug dosing in obese adults","volume":"40","author":"Barras","year":"2017","journal-title":"Aust. Prescr."},{"issue":"1147","key":"10.1016\/j.cbi.2023.110351_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/postgradmedj-2020-137542","article-title":"Effects of waist to height ratio, waist circumference, body mass index on the risk of chronic diseases, all-cause, cardiovascular and cancer mortality","volume":"97","author":"Lo","year":"2021","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.cbi.2023.110351_bib4","first-page":"549","article-title":"Weight-based dosing in medication use: what should we know?","volume":"10","author":"Pan","year":"2016","journal-title":"Patient Prefer. Adherence"},{"issue":"1","key":"10.1016\/j.cbi.2023.110351_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/aian.AIAN_201_18","article-title":"Propranolol: a 50-year historical perspective","volume":"22","author":"Srinivasan","year":"2019","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"5680","key":"10.1016\/j.cbi.2023.110351_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/bmj.4.5680.399","article-title":"Mechanism of action of \u03b2adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol","volume":"4","author":"Wilson","year":"1969","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.cbi.2023.110351_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.cbi.2023.110351_bib9","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic efficiency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110351_bib10","doi-asserted-by":"crossref","unstructured":"Bunally, S. B., Luscombe, C. N., & Young, R. J. Using Physicochemical Measurements to Influence Better Compound Design. SLAS Discov., 24(8), 791-801. :https:\/\/doi.org\/10.1177\/2472555219859845.","DOI":"10.1177\/2472555219859845"},{"issue":"8","key":"10.1016\/j.cbi.2023.110351_bib11","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2023.110351_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5863\/1551-6776-22.1.81","article-title":"Medication dosage in overweight and obese children","volume":"22","author":"Matson","year":"2017","journal-title":"J. Pediatr. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.cbi.2023.110351_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1552-4604.1987.tb05582.x","article-title":"Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers","volume":"27","author":"Cheymol","year":"1987","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.cbi.2023.110351_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.2042-7158.1990.tb05423.x","article-title":"Comparison of propranolol and sotalol pharmacokinetics in obese subjects","volume":"42","author":"Poirier","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2023.110351_bib15","first-page":"959","article-title":"[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects]","volume":"174","author":"Cheymol","year":"1990","journal-title":"Bull. Acad. Natl. Med."},{"issue":"6","key":"10.1016\/j.cbi.2023.110351_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2125.1997.00609.x","article-title":"Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers","volume":"43","author":"Cheymol","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2023.110351_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1590\/S1516-93322003000400008","article-title":"Obesity influences propranolol pharmacokinetics in patients undergoing coronary artery bypass grafting employing cardiopulmonary bypass","volume":"39","author":"Pereira","year":"2003","journal-title":"Rev. Bras. Ciencias Farm."},{"issue":"5","key":"10.1016\/j.cbi.2023.110351_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bdd.357","article-title":"Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects","volume":"24","author":"W\u00f3jcicki","year":"2003","journal-title":"Biopharm Drug Dispos."},{"issue":"5","key":"10.1016\/j.cbi.2023.110351_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2125.1986.tb02837.x","article-title":"A comparison of the pharmacokinetics of propranolol in obese and normal volunteers","volume":"21","author":"Bowman","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2023.110351_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003088-199325020-00003","article-title":"Clinical pharmacokinetics of drugs in obesity","volume":"25","author":"Cheymol","year":"1993","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.cbi.2023.110351_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1152\/jappl.1967.23.5.621","article-title":"Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr","volume":"23","author":"Lesser","year":"1967","journal-title":"J. Appl. Physiol."},{"issue":"6","key":"10.1016\/j.cbi.2023.110351_bib22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.CIR.67.6.1178","article-title":"Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease","volume":"67","author":"Kern","year":"1983","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cbi.2023.110351_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00265912","article-title":"Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers","volume":"41","author":"Le Jeunne","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.cbi.2023.110351_bib24","first-page":"647","article-title":"Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents","volume":"45","author":"Barbato","year":"1990","journal-title":"Farmaco"},{"key":"10.1016\/j.cbi.2023.110351_bib25","first-page":"55","article-title":"Factors affecting the storage of drugs and other xenobiotics in adipose tissue","volume":"25","author":"Bickel","year":"1994","journal-title":"Adv. Drug Res."},{"issue":"6","key":"10.1016\/j.cbi.2023.110351_bib26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2125.1984.tb02567.x","article-title":"Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects","volume":"18","author":"Benedek","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.cbi.2023.110351_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2125.1983.tb02258.x","article-title":"Serum alpha 1-acid glycoprotein and the binding of drugs in obesity","volume":"16","author":"Benedek","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2023.110351_bib28","first-page":"114","article-title":"The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat","volume":"186","author":"Evans","year":"1973","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"suppl 1","key":"10.1016\/j.cbi.2023.110351_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000170647","article-title":"\u03b2-Adrenoceptor-Blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol","volume":"64","author":"Meier","year":"1979","journal-title":"Cardiology"},{"key":"10.1016\/j.cbi.2023.110351_bib30","first-page":"5","article-title":"Pharmacological properties of beta-adrenoceptor blocking drugs","volume":"1","author":"Borchard","year":"1998","journal-title":"J. Clin. Basic Cardiol."},{"issue":"2","key":"10.1016\/j.cbi.2023.110351_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-5223(19)39947-7","article-title":"Potassium replacement during cardiopulmonary bypass","volume":"73","author":"Babka","year":"1977","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"8","key":"10.1016\/j.cbi.2023.110351_bib32","first-page":"2919","article-title":"Microdialysis of adipose tissue during surgery: effect of local alpha- and beta-adrenoceptor blockade on blood flow and lipolysis","volume":"81","author":"Fell\u00e4nder","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cbi.2023.110351_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jconrel.2005.06.019","article-title":"Clinical bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire\u00ae core","volume":"107","author":"Mehuys","year":"2005","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.cbi.2023.110351_bib34","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.lfs.2006.03.021","article-title":"High-fat emulsion-induced rat model of nonalcoholic steatohepatitis","volume":"79","author":"Zou","year":"2006","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.cbi.2023.110351_bib35","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3109\/00498254.2014.932470","article-title":"Role of hepatic blood flow and metabolism in the pharmacokinetics of ten drugs in lean, aged and obese rats","volume":"44","author":"Subramanian","year":"2014","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.cbi.2023.110351_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/dmd.110.036806","article-title":"Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metabol. Dispos."},{"issue":"1","key":"10.1016\/j.cbi.2023.110351_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in clinical adipose tissues - the biology of pear shape","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol. Sex Differ."},{"issue":"3","key":"10.1016\/j.cbi.2023.110351_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1989.136","article-title":"Pathway-selective sex differences in the metabolic clearance of propranolol in clinical subjects","volume":"46","author":"Walle","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cbi.2023.110351_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.cbi.2023.110351_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2125.1980.tb01736.x","article-title":"Effect of age on plasma propranolol levels [letter]","volume":"10","author":"Schneider","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2023.110351_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.CIR.52.1.6","article-title":"Clinical pharmacology of propranolol","volume":"52","author":"Nies","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2023.110351_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/B978-0-444-59427-3.00019-8","article-title":"The impact of the circadian timing system on cardiovascular and metabolic function","volume":"199","author":"Morris","year":"2012","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.1016\/j.cbi.2023.110351_bib43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/10641963.2013.780073","article-title":"Toward a personalized chronotherapy of high blood pressure and a circadian overswing","volume":"35","author":"Watanabe","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.cbi.2023.110351_bib44","article-title":"Timed, sustained release systems for propranolol.(American Patent No US6500454 B1)","author":"Percel","year":"2002","journal-title":"United States Pat. Trademark Off."},{"key":"10.1016\/j.cbi.2023.110351_bib45","series-title":"Timed, Pulsatile Release Systems","author":"Venkatesh","year":"2006"},{"key":"10.1016\/j.cbi.2023.110351_bib46","series-title":"Circadian Rhythms in Diet-Induced Obesity","author":"Engin","year":"2017"},{"issue":"6","key":"10.1016\/j.cbi.2023.110351_bib47","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200702","article-title":"Personalized medicine and circadian rhythms: opportunities for modern society","volume":"217","author":"Greco","year":"2020","journal-title":"J. Exp. Med."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:35:55Z","timestamp":1736368555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"alternative-id":["S0009279723000182"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110351","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110351"}}